MAX Chat
Company Analysis Bruker Corporation
1. Summary
Advantages
- The company's current efficiency (ROE=7.16%) is higher than the sector average (ROE=-70.06%)
Disadvantages
- Price (30.91 $) is higher than fair price (8.73 $)
- Dividends (0.4902%) are below the sector average (1.35%).
- The stock's return over the last year (-51.18%) is lower than the sector average (-31.11%).
- Current debt level 38.67% has increased over 5 years from 29.35%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Bruker Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.3% | -13% | 1.3% |
| 90 days | -19.3% | -12.2% | 11.9% |
| 1 year | -51.2% | -31.1% | 17.1% |
BRKR vs Sector: Bruker Corporation has significantly underperformed the "Healthcare" sector by -20.08% over the past year.
BRKR vs Market: Bruker Corporation has significantly underperformed the market by -68.3% over the past year.
Stable price: BRKR is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BRKR with weekly volatility of -0.9843% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (30.91 $) is higher than the fair price (8.73 $).
Price is higher than fair: The current price (30.91 $) is 71.8% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (77.33) is higher than that of the sector as a whole (27.8).
P/E vs Market: The company's P/E (77.33) is higher than that of the market as a whole (51.16).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.82) is lower than that of the sector as a whole (10.5).
P/BV vs Market: The company's P/BV (4.82) is lower than that of the market as a whole (18.11).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.6) is lower than that of the sector as a whole (4.08).
P/S vs Market: The company's P/S indicator (2.6) is lower than that of the market as a whole (27.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (24.64) is higher than that of the sector as a whole (18.1).
EV/Ebitda vs Market: The company's EV/Ebitda (24.64) is lower than that of the market as a whole (36.52).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.67% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.67%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (1364.84%).
5.4. ROE
ROE vs Sector: The company's ROE (7.16%) is higher than that of the sector as a whole (-70.06%).
ROE vs Market: The company's ROE (7.16%) is lower than that of the market as a whole (34.73%).
5.5. ROA
ROA vs Sector: The company's ROA (2.25%) is lower than that of the sector as a whole (8.48%).
ROA vs Market: The company's ROA (2.25%) is lower than that of the market as a whole (11.48%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (21.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.02%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4902% is below the average for the sector '1.35%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4902% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.4902% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (26.7%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
